Keren Haruvi Reelected Chair of the Association for Accessible Medicines Board of Directors
WASHINGTON (January 22, 2025) — The Board of Directors of the Association for Accessible Medicines has reelected as Chair for a second one-year term, Keren Haruvi, President, Sandoz North America. The Board also reconfirmed for a second term Bob Hoffman, Chief Commercial Officer of US Generics for Lupin Pharmaceuticals, Inc. as Vice Chair of the […]
John Murphy Named President and CEO of AAM
Brings years of industry, policy, and association leadership experience WASHINGTON, DC (September 25, 2024) – The Association for Accessible Medicines Board of Directors today announced the appointment of John A. Murphy III to be the association’s President and Chief Executive Officer. Mr. Murphy will join AAM in October. Mr. Murphy most recently served as the […]
Keren Haruvi Named Chair of the Association for Accessible Medicines Board of Directors
WASHINGTON D.C. (January 23, 2024) — The Board of Directors of the Association for Accessible Medicines (AAM) has named as its new Chairperson, Keren Haruvi, President of Sandoz North America, who was elected for a one-year term. “I am honored and excited about the opportunity to be the Association for Accessible Medicines Board of Directors Chair […]
Keren Haruvi Announced as Chair of the Association for Accessible Medicines Board of Directors
WASHINGTON D.C. (December 8, 2023) — Keren Haruvi today was announced as the new chairperson of the Board of Directors of the Association for Accessible Medicine. She is President of Sandoz North America and most recently served as Vice Chair of the Board of AAM. Haruvi succeeds Christine Baeder, who recently left her position as […]
AAM Announces 2023 Board of Directors
WASHINGTON, DC (February 16, 2023) —The Association for Accessible Medicines (AAM) today announced the election of its 2023 Board of Directors and Officers. Ms. Christine Baeder, Senior Vice President & Chief Operating Officer for US Generics, Teva Pharmaceuticals USA, Inc. is the 2023 AAM Chair of the Board. AAM also named Ms. Keren Haruvi, President, […]
Christine Baeder Named Chair of the Association for Accessible Medicines Board of Directors
ORLANDO, FL (February 14, 2023) — The Board of Directors of the Association for Accessible Medicines (AAM) has named as its new Chairperson, Christine Baeder, Teva Pharmaceuticals USA Chief Operating Officer for U.S. Generics and Biosimilars. Baeder succeeds Chirag Patel, Amneal Pharmaceuticals Inc.’s Co-Founder, President, and Co-Chief Executive Officer, as AAM Board of Directors Chairman. […]
Association for Accessible Medicines (AAM) Elevates David Gaugh to Executive Vice President for Sciences & Regulatory Affairs
WASHINGTON, D.C. (July 28, 2022) – The Association for Accessible Medicines (AAM) announced today that David Gaugh has been promoted to Executive Vice President for Sciences & Regulatory Affairs. David recently represented the generic and biosimilar medicine industries in the complex multilateral negotiations over FDA user fees which will, upon Congressional approval, extend the program […]
Giuseppe Randazzo Joins AAM as Vice President, Sciences and Regulatory Affairs
WASHINGTON, D.C. (June 6, 2022) – The Association for Accessible Medicines (AAM) announced the appointment of Giuseppe Randazzo as Vice President of Sciences and Regulatory Affairs, effective June 6. In that role, Giuseppe will advise and support association leadership with respect to key developments and relationships within the industry’s regulatory landscape and work with members […]
Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council
WASHINGTON, DC (May 16, 2022) – The Association for Accessible Medicines (AAM) and its Board of Directors announced the promotion of Craig Burton to Senior Vice President, Policy & Strategic Alliances, effective May 30, 2022. He will also become the Executive Director of the Biosimilars Council, which is the preeminent voice advocating in Washington and […]
AAM Lifetime Achievement Award – Joe Renner
Zydus Chairman Joe Renner accepted the Association for Accessible Medicines (AAM) Lifetime Achievement Award at AAM’s annual meeting February 15 in Orlando, Florida. Leaders in the industry joined together for a tribute video marking the occasion.
AAM Announces 2022 Board of Directors
WASHINGTON, DC (February 14, 2022) — The Association for Accessible Medicines (AAM) announced the election of its 2022 Board of Directors and Officers today. Chirag Patel, President and Co-Chief Executive Officer, Amneal Pharmaceuticals Inc. is the 2022 AAM Chair of the Board. AAM also named Christine Baeder, Senior Vice President, Chief Operating Officer for US […]
Black History Month: 10 Pioneers to Celebrate
The generics and biosimilars industry is always pushing ahead into the future, drawing on the latest breakthroughs to advance the cause of health care access. This forward-facing stance, however, requires that we understand and appreciate the pioneers in biology, medical science and pharmacy who make our work possible. Many of those figures overcame racism and […]
